Long-term safety follow-up for CTX0E03 after PISCES III
Part of Brain & nervous system, Heart & circulation clinical trials.
This study checks how safe CTX0E03 is over the long term in people who already received it in a previous PISCES III trial. It may help confirm long-term safety information for future patients, and you may contribute valuable follow-up data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You took part in the PISCES III study.
- You received CTX0E03 during the active (treatment) part of PISCES III.
- You signed (or can sign) written informed consent for this follow-up study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication called LWP779 in healthy adults to see if it is safe and how the body processes it. It helps determine the right dose for future studies.
This study looks for biological and imaging markers that may predict heart/vascular outcomes after an ischemic stroke. You may join if you are eligible for standard stroke treatment and can complete planned follow-up and MRI scans.
This study follows patients who come to the hospital with a brain blood vessel emergency, such as a stroke. Researchers want to learn more about these conditions and how patients do over time, which may help improve care for others in the future. You would not receive any new treatment, but your health information would be tracked.
This trial looks at the long-term effects of regular exercise for people with narrowed brain arteries. It follows participants from a previous study to see if exercise continues to help over three more years.
This study is a long-term follow-up for people with epilepsy who already completed a previous trial of the drug CB03-154. It checks if the drug remains safe and effective over more time.
This study follows people for a long time after they received CTX001 in an earlier (parent) study. It helps researchers learn about long-term safety and outcomes of the treatment.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.